Clinical Trial Evidence: What the Data Shows
Is Wegovy Better Than Mounjaro: Understanding the Clinical Evidence
When evaluating whether Wegovy is better than Mounjaro, examining the robust clinical trial data provides essential insights for UK patients. Wegovy (semaglutide) demonstrated remarkable efficacy in the landmark STEP clinical programme, with patients achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The STEP 1 trial specifically showed that 83.5% of participants achieved at least clinically studied weight loss, while 66.1% reached 10% or greater weight reduction.
Mounjaro (tirzepatide) operates through a dual GIP and GLP-1 receptor agonist mechanism, offering a different therapeutic approach. Both treatments require prescription-only medicine status and must be used alongside a reduced-calorie diet and increased physical activity. The question of whether Wegovy is better than Mounjaro ultimately depends on individual patient factors, tolerance profiles, and clinical response, which your prescriber can help evaluate through our comprehensive assessment process.
Wegovy vs Mounjaro Pricing: UK Cost Comparison and Value
Understanding the cost implications when asking "is Wegovy better than Mounjaro" requires examining both immediate expenses and long-term value. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. Our bundle options provide convenient supply management, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, ensuring seamless dose escalation without multiple orders.
New customers benefit from discount code FIRST40, while returning patients use DOSE25 at checkout to access these competitive prices. The investment in either Wegovy or Mounjaro represents a commitment to evidence-based weight management under medical supervision. Both medications are available through our streamlined service, with standard prescriber review taking 3 working days or express 24-hour options available for urgent requirements.
STEP Trial Results: Wegovy's Clinical Foundation
The STEP clinical programme provides compelling evidence when considering is Wegovy better than Mounjaro from an established research perspective. STEP 1 enrolled 1,961 adults without diabetes, demonstrating sustained weight reduction over 68 weeks with Wegovy treatment. STEP 3 combined Wegovy with intensive behavioural therapy, achieving approximately 16% average weight loss, while STEP 5 confirmed long-term sustainability with 15.2% maintained reduction at 2 years.
The recent SELECT cardiovascular outcomes trial revealed an additional benefit, showing 20% reduction in major cardiovascular events among participants taking Wegovy. These studies consistently used the same dose escalation protocol we follow at EverydayMeds, starting with 0.25mg weekly and gradually increasing to the 2.4mg maintenance dose over 16 weeks, ensuring optimal tolerance and efficacy.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding whether Wegovy is better than Mounjaro requires grasping their distinct mechanisms of action, with Wegovy functioning as a selective GLP-1 receptor agonist. This prescription-only medicine mimics the natural incretin hormone GLP-1, which regulates appetite and food intake through brain signalling pathways. Wegovy reduces hunger sensations, promotes earlier satiety during meals, and may decrease food cravings by acting on appetite control centres. The once-weekly FlexTouch pen delivery system maintains steady semaglutide levels, providing consistent appetite regulation throughout the week. This targeted approach has proven effective across diverse patient populations in clinical trials, offering a well-understood therapeutic pathway for weight management.
EverydayMeds Ordering Process: From Assessment to Delivery
Our streamlined process makes accessing Wegovy simple while maintaining clinical safety standards required for this prescription-only medicine. The journey begins with our 3-minute online clinical assessment, designed by healthcare professionals to evaluate your suitability for Wegovy treatment. Following submission, our qualified prescribers review your information within 3 working days (or 24 hours with express service), ensuring appropriate medical oversight. Once approved, your Wegovy pen ships via next-day cold-chain delivery, maintaining the crucial 2-8°C temperature throughout transit. Our GPhC #9012878 registered pharmacy ensures every order meets pharmaceutical standards, from storage through delivery to your door.
Storage Advantages: Wegovy's Practical Benefits
When evaluating is Wegovy better than Mounjaro for practical daily use, storage convenience presents a notable advantage for UK patients. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability proves valuable for travel, work schedules, or situations where refrigeration access is limited. The FlexTouch pen system delivers precise dosing with each weekly injection, while the clear dose escalation schedule (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) provides predictable progression. Proper storage in the fridge at 2-8°C before first use ensures medication potency throughout the treatment period.
Is Wegovy Better Than Mounjaro: Individual Response Factors
The question of whether Wegovy is better than Mounjaro cannot be answered universally, as individual patient response varies significantly based on medical history, current medications, and tolerance profiles. Wegovy's single GLP-1 receptor agonist mechanism may suit patients who prefer a well-established therapeutic approach with extensive long-term data. Some individuals respond more favourably to Wegovy's specific semaglutide formulation, while others may benefit from Mounjaro's dual receptor targeting.
Your prescriber considers multiple factors when recommending between these treatments, including BMI, comorbidities, previous weight loss attempts, and potential drug interactions. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your healthcare provider flexibility in prescribing the most appropriate option for your circumstances. The clinical assessment process ensures personalised treatment selection based on your unique medical profile rather than generalised comparisons.
Making Your Decision: Next Steps with EverydayMeds
Rather than definitively answering "is Wegovy better than Mounjaro," the evidence suggests both treatments offer significant benefits for appropriate patients under medical supervision. Wegovy's established STEP trial programme, convenient storage properties, and proven cardiovascular benefits provide compelling advantages for many UK patients seeking effective weight management. Our comprehensive service includes ongoing support throughout your treatment journey, from initial assessment through maintenance dosing. Remember to apply discount code FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing. Both Wegovy and Mounjaro are available from EverydayMeds – your prescriber can help determine which treatment aligns best with your health goals and medical history.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
